Dual RAAS blockade is desirable in kidney disease: Con-Reference-Cited by-同舟云学术

Dual RAAS blockade is desirable in kidney disease: Con

Published:2010-09 Issue:6 Volume:78 Page:546-549
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Bakris George L.

Publisher

Elsevier BV

Subject

Nephrology

Reference24 articles.

1. Incidence of end-stage renal disease among persons with diabetes–United States, 1990-2002;Centers for Disease Control and Prevention (CDC);MMWR Morb Mortal Wkly Rep,2005

2. End-stage renal disease in the United States: an update from the United States Renal Data System;Foley;J Am Soc Nephrol,2007

3. Surrogate endpoints in clinical trials: definition and operational criteria;Prentice;Stat Med,1989

4. Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration;Levey;Am J Kidney Dis,2009

5. The current state of RAAS blockade in the treatment of hypertension and proteinuria;Kalaitzidis;Curr Cardiol Rep,2009

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Renin Angiotensin-Aldosterone System in Kidney Homeostasis;The Renin Angiotensin System in Cancer, Lung, Liver and Infectious Diseases;2023

2. An Overview of Clinically Imperative and Pharmacodynamically Significant Drug Interactions of Renin-Angiotensin-Aldosterone System (RAAS) Blockers;Current Cardiology Reviews;2022-11

3. Benefits and risks of dual inhibition of the renin– angiotensin aldosterone system for kidney disease;Journal of Renal Injury Prevention;2021-11-05

4. Benefits and risks of dual inhibition of the renin-angiotensin aldosterone system for kidney disease;J RENAL INJ PREV;2021

5. The Dilemma of Dual Renin-Angiotensin System Blockade in Chronic Kidney Disease: Why Beneficial in Animal Experiments But Not in the Clinic?;Physiological Research;2017-04-16